Monitoring interactions inside cells by advanced spectroscopies: Overview of 
copper transporters and cisplatin.

Lasorsa, A.; Natile, G.; Rosato, A.; Tadini-Buoninsegni , F.; Arnesano , F.

doi:10.1174/0919867314666171110141311

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

このアイテムの新しいバージョンが利用可能です:
https://pure.mpg.de/pubman/item/item_2558401_5

詳細要約

公開

学術論文

Monitoring interactions inside cells by advanced spectroscopies: Overview of copper transporters and cisplatin.

MPS-Authors

/persons/resource/persons217504

Lasorsa, A.
Research Group of Protein Structure Determination using NMR, MPI for Biophysical Chemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Lasorsa, A., Natile, G., Rosato, A., Tadini-Buoninsegni, F., & Arnesano, F. (2018). Monitoring interactions inside cells by advanced spectroscopies: Overview of copper transporters and cisplatin. Current Medicinal Chemistry, 25(4), 462-477. doi:10.1174/0919867314666171110141311.

引用: https://hdl.handle.net/21.11116/0000-0000-D04D-F

要旨

Background: Resistance, either at the onset of the treatment or developed after an initial positive response, is a major limitation of antitumor therapy. In the case of platinum-based drugs, copper transporters have been found to interfere with drug trafficking by facilitating the import or favoring the platinum export and inactivation. Methods: The use of powerful spectroscopic, spectrometric and computational methods has allowed a deep structural insight into the mode of interaction of platinum drugs with the metal-binding domains of the transporter proteins. Results: This review article focuses on the mode in which platinum drugs can compete with copper ion for binding to transport proteins and consequent structural and biological effects. Three types of transporters are discussed in detail: copper transporter 1 (Ctrl), the major responsible for Cu+ uptake; antioxidant-1 copper chaperone (Atoxl), responsible for copper transfer within the cytoplasm; and copper ATPases (ATP7A/B), responsible for copper export into specific subcellular compartments and outside the cell. Conclusion: The body of knowledge summarized in this review can help in shaping current chemotherapy to optimize the efficacy of platinum drugs (particularly in relation to resistance) and to mitigate adverse effects on copper metabolism.